Agilent Technologies Pre-Tax Profit Margin 2010-2025 | A
Current and historical pre-tax profit margin for Agilent Technologies (A) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Agilent Technologies pre-tax profit margin for the three months ending April 30, 2025 was .
| Agilent Technologies Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-04-30 | $6.63B | $1.37B | 20.68% |
| 2025-01-31 | $6.53B | $1.49B | 22.73% |
| 2024-10-31 | $6.51B | $1.52B | 23.36% |
| 2024-07-31 | $6.50B | $1.54B | 23.70% |
| 2024-04-30 | $6.59B | $1.33B | 20.16% |
| 2024-01-31 | $6.74B | $1.33B | 19.78% |
| 2023-10-31 | $6.83B | $1.34B | 19.60% |
| 2023-07-31 | $6.99B | $1.37B | 19.65% |
| 2023-04-30 | $7.04B | $1.64B | 23.28% |
| 2023-01-31 | $6.93B | $1.60B | 23.02% |
| 2022-10-31 | $6.85B | $1.50B | 21.96% |
| 2022-07-31 | $6.66B | $1.50B | 22.48% |
| 2022-04-30 | $6.53B | $1.43B | 21.86% |
| 2022-01-31 | $6.45B | $1.37B | 21.21% |
| 2021-10-31 | $6.32B | $1.36B | 21.52% |
| 2021-07-31 | $6.14B | $1.20B | 19.46% |
| 2021-04-30 | $5.82B | $1.09B | 18.69% |
| 2021-01-31 | $5.53B | $0.94B | 16.91% |
| 2020-10-31 | $5.34B | $0.84B | 15.77% |
| 2020-07-31 | $5.22B | $0.79B | 15.13% |
| 2020-04-30 | $5.24B | $0.79B | 15.15% |
| 2020-01-31 | $5.24B | $0.89B | 17.00% |
| 2019-10-31 | $5.16B | $0.92B | 17.80% |
| 2019-07-31 | $5.09B | $0.93B | 18.31% |
| 2019-04-30 | $5.02B | $0.95B | 18.97% |
| 2019-01-31 | $4.99B | $0.96B | 19.27% |
| 2018-10-31 | $4.91B | $0.95B | 19.25% |
| 2018-07-31 | $4.81B | $0.93B | 19.30% |
| 2018-04-30 | $4.72B | $0.88B | 18.62% |
| 2018-01-31 | $4.62B | $0.84B | 18.26% |
| 2017-10-31 | $4.47B | $0.80B | 17.96% |
| 2017-07-31 | $4.39B | $0.73B | 16.57% |
| 2017-04-30 | $4.32B | $0.67B | 15.47% |
| 2017-01-31 | $4.24B | $0.60B | 14.03% |
| 2016-10-31 | $4.20B | $0.54B | 12.95% |
| 2016-07-31 | $4.13B | $0.54B | 12.99% |
| 2016-04-30 | $4.10B | $0.53B | 12.94% |
| 2016-01-31 | $4.04B | $0.51B | 12.60% |
| 2015-10-31 | $4.04B | $0.48B | 11.89% |
| 2015-07-31 | $4.81B | $0.42B | 8.78% |
| 2015-04-30 | $4.80B | $0.38B | 7.89% |
| 2015-01-31 | $4.83B | $0.35B | 7.29% |
| 2014-10-31 | $4.81B | $0.34B | 6.99% |
| 2014-07-31 | $4.72B | $0.51B | 10.69% |
| 2014-04-30 | $5.37B | $0.63B | 11.78% |
| 2014-01-31 | $6.11B | $0.76B | 12.45% |
| 2013-10-31 | $6.78B | $0.86B | 12.67% |
| 2013-07-31 | $6.83B | $0.86B | 12.60% |
| 2013-04-30 | $6.90B | $0.89B | 12.85% |
| 2013-01-31 | $6.90B | $0.98B | 14.23% |
| 2012-10-31 | $6.86B | $1.04B | 15.21% |
| 2012-07-31 | $6.82B | $1.08B | 15.84% |
| 2012-04-30 | $6.79B | $1.12B | 16.55% |
| 2012-01-31 | $6.73B | $1.09B | 16.19% |
| 2011-10-31 | $6.62B | $1.03B | 15.60% |
| 2011-07-31 | $6.46B | $0.98B | 15.19% |
| 2011-04-30 | $6.16B | $0.93B | 15.07% |
| 2011-01-31 | $5.75B | $0.81B | 14.03% |
| 2010-10-31 | $5.44B | $0.69B | 12.71% |
| 2010-07-31 | $5.04B | $0.53B | 10.49% |
| 2010-04-30 | $4.71B | $0.26B | 5.52% |
| 2010-01-31 | $4.53B | $0.06B | 1.39% |
| 2009-10-31 | $4.48B | $0.01B | 0.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.835B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.506B | 27.03 |
| Boston Scientific (BSX) | United States | $157.140B | 37.47 |
| Stryker (SYK) | United States | $149.815B | 30.50 |
| EssilorLuxottica (ESLOY) | France | $148.753B | 0.00 |
| Medtronic (MDT) | Ireland | $119.490B | 16.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.052B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.480B | 25.41 |
| ResMed (RMD) | United States | $42.323B | 30.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.726B | 15.85 |
| Terumo (TRUMY) | Japan | $27.731B | 32.86 |
| Koninklijke Philips (PHG) | Netherlands | $26.731B | 17.68 |
| Insulet (PODD) | United States | $23.441B | 78.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.941B | 13.33 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.385B | 0.00 |
| Baxter (BAX) | United States | $12.466B | 9.63 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.798B | 28.64 |
| Lantheus Holdings (LNTH) | United States | $3.817B | 10.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.443B | 24.09 |
| Perrigo (PRGO) | Ireland | $3.255B | 8.13 |
| Prestige Consumer Healthcare (PBH) | United States | $3.201B | 14.20 |
| ICU Medical (ICUI) | United States | $3.045B | 20.73 |
| Haemonetics (HAE) | United States | $2.623B | 11.71 |
| LeMaitre Vascular (LMAT) | United States | $2.189B | 46.95 |
| AtriCure (ATRC) | United States | $1.793B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.789B | 11.26 |
| Curaleaf Holdings (CURLF) | Canada | $1.750B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.687B | 72.46 |
| AdaptHealth (AHCO) | United States | $1.262B | 17.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Acuren (TIC) | United States | $1.220B | 0.00 |
| Neogen (NEOG) | United States | $1.210B | 19.21 |
| BioLife Solutions (BLFS) | United States | $1.196B | 2496.00 |
| Tilray Brands (TLRY) | Canada | $1.167B | 0.00 |
| Valneva SE (VALN) | France | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 8.30 |
| Kestra Medical Technologies (KMTS) | United States | $0.852B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.626B | 0.00 |
| SNDL (SNDL) | Canada | $0.581B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.557B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.535B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.528B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.466B | 16.04 |
| CeriBell (CBLL) | United States | $0.425B | 0.00 |
| Owens & Minor (OMI) | United States | $0.412B | 3.66 |
| Sanuwave Health (SNWV) | United States | $0.338B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.290B | 0.00 |
| Omeros (OMER) | United States | $0.285B | 0.00 |
| Brainsway (BWAY) | Israel | $0.279B | 56.81 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 20.18 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Quanterix (QTRX) | United States | $0.228B | 0.00 |
| Cerus (CERS) | United States | $0.222B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.201B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.47 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.34 |
| Biote (BTMD) | United States | $0.147B | 4.87 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.10 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 31.80 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 34.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.21 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.031B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |